Use of magnoflorine-phospholipid complex to permeate blood-brain barrier and treat depression in the CUMS animal model. (1st January 2019)
- Record Type:
- Journal Article
- Title:
- Use of magnoflorine-phospholipid complex to permeate blood-brain barrier and treat depression in the CUMS animal model. (1st January 2019)
- Main Title:
- Use of magnoflorine-phospholipid complex to permeate blood-brain barrier and treat depression in the CUMS animal model
- Authors:
- Li, Bingjie
Han, Linmeng
Cao, Bingyan
Yang, Xiaoying
Zhu, Xuehui
Yang, Bing
Zhao, Haodong
Qiao, Wei - Abstract:
- Abstract: To improve the liposolubility and blood-brain barrier permeability of magnoflorine, a new formulation of magnoflorine-phospholipid complex was prepared, characterized, and pharmacologically evaluated in the chronic unpredictable mild stress animal model. In this paper, the magnoflorine-phospholipid complex was synthesized and its characterization was determined. The antidepressant-like and antioxidant activity of magnoflorine-phospholipid complex was investigated by behavioral tests and western blotting analysis. As a result, the magnoflorine-phospholipid complex displayed high encapsulation efficiency and significantly improved the oil-water participate coefficient. In vivo blood-brain distribution study, the magnoflorine-phospholipid complex extended the duration of magnoflorine in blood and help magnoflorine to permeate the blood-brain barrier into brain. In behavioral tests, the magnoflorine-phospholipid complex significantly decreased immobility time compared to model control group in both FST and TST. Furthermore, the magnoflorine-phospholipid complex increased the expression of antioxidative stress-related proteins by the western blotting analysis. These findings strongly suggest that the phospholipid complex could significantly improve liposolubility, drug properties of magnoflorine and help magnoflorine permeate blood-brain barrier and exert the antidepressant effect.
- Is Part Of:
- Drug delivery. Volume 26:Number 1(2019)
- Journal:
- Drug delivery
- Issue:
- Volume 26:Number 1(2019)
- Issue Display:
- Volume 26, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2019-0026-0001-0000
- Page Start:
- 566
- Page End:
- 574
- Publication Date:
- 2019-01-01
- Subjects:
- Magnoflorine-phospholipid complex -- physicochemical characterization -- in vivo blood-brain distribution -- pharmacological evaluation -- western blotting analysis
Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10717544.2019.1616236 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17154.xml